Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Acotec Scientific Holdings's Enterprise Value is HK$1,289.7 Mil.
Acotec Scientific Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$75.1 Mil. Therefore, Acotec Scientific Holdings's EV-to-FCF for today is 17.16.
The historical rank and industry rank for Acotec Scientific Holdings's EV-to-FCF or its related term are showing as below:
HKSE:06669'
s EV-to-FCF Range Over the Past 10 Years
Min: -170.83 Med: -15.38 Max: 640.05
Current: 18.39
During the past 7 years, the highest EV-to-FCF of Acotec Scientific Holdings was 640.05. The lowest was -170.83. And the median was -15.38.
HKSE:06669's EV-to-FCF is ranked better than 64.95% of 408
companies
in the Medical Devices & Instruments industry
Industry Median: 24.28
vs HKSE:06669: 18.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Acotec Scientific Holdings's PE Ratio (TTM) for today is calculated as:
Acotec Scientific Holdings's share price for today is HK$6.365.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acotec Scientific Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.202.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Acotec Scientific Holdings EV-to-FCF Related Terms
Acotec Scientific Holdings EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Acotec Scientific Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's EV-to-FCF falls into.
Acotec Scientific Holdings's current Enterprise Value is HK$1,289.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acotec Scientific Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$75.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acotec Scientific Holdings (HKSE:06669) has a EV-to-FCF of 17.16 as of Sep. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Acotec Scientific Holdings and its competitors. According to the industry distribution chart, Acotec Scientific Holdings ranks #143 out of 408 companies in the Medical Devices & Instruments industry, placing it in the top 35%.
Is Acotec Scientific Holdings' EV-to-FCF too high?
Acotec Scientific Holdings' current EV-to-FCF is 17.16. The Medical Devices & Instruments industry median EV-to-FCF is 24.28. Acotec Scientific Holdings' value of 17.16 is 29.3% below this industry median. Based on the distribution chart, Acotec Scientific Holdings ranks #143 out of 408 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Acotec Scientific Holdings ranks #143 out of 408 companies for EV-to-FCF. This puts Acotec Scientific Holdings in the upper half of its industry. The industry median EV-to-FCF is 24.28. Acotec Scientific Holdings' value of 17.16 is 29.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.28, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acotec Scientific Holdings's current EV-to-FCF of 17.16 is 29.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Acotec Scientific Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acotec Scientific Holdings's current EV-to-FCF is 17.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.83, compared to a current price of HK$6.37 — trading 57.1% below its estimated fair value. The current EV-to-FCF is 17.16 and 29.3% below the Medical Devices & Instruments industry median of 24.28. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current EV-to-FCF is 17.16 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?
Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued.
The current stock price of HK$6.37 is trading 57.1% below its estimated GF Value™ of HK$14.83.
GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:06669:
EV-to-FCF: 17.16
GF Value™: HK$14.83 vs. price of HK$6.37 (57.1% below fair value)
Industry Position: 29.3% below the Medical Devices & Instruments median (#143 of 408)
No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score
Get the complete analysis for HKSE:06669
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06669 has been successfully added to your 
